EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Benefits of Short-Term (4-Week) Daily Walnut Consumption in Middle-Aged Adults at Risk for Metabolic Syndrome: Outcomes of a Randomized Controlled Trial

Letiția Mateș iD, Doina Albert-Ani, Ionel Fizeșan, Andreea-Elena Petru iD, Roxana Banc iD, Marius Emil Rusu iD, Carmen Costache iD, Lorena Filip iD, Daniela-Saveta Popa iD, Daniel-Corneliu Leucuța iD

Nutrients · 2025

DOI: 10.3390/nu17132072 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Letiția Mateș und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Juglans, Metabolic Syndrome, Nuts, Diet. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epidemiological research has shown that regular walnut (from Juglans regia L.) consumption is associated with a reduced risk of cardiovascular disease (CVD), potentially attributable to their antioxidant and anti-inflammatory properties. The vascular cellular adhesion molecule-1 (VCAM-1), a protein upregulated in CVD, has been previously examined in relation to walnut consumption. However, the clinical findings regarding the effects of walnuts on endothelial function among middle-aged individuals susceptible to metabolic syndrome (MetS) remain inconclusive.

Objective

This study examined the effects of daily walnut consumption over a four-week period on cardiometabolic parameters (lipid and glycemic profiles, as well as soluble VCAM-1 levels) and anthropometric measurements in middle-aged individuals with at least one altered MetS parameter and no medication.

Methods

In a randomized controlled cross-over trial, 22 eligible Caucasian participants (48.81 ± 4.3 years) were selected and randomly assigned to receive either 45 g of walnuts per day or no walnuts within a controlled diet. There were two 28-day intervention periods, with a one-month washout period in between. Clinical and biochemical evaluations were conducted at the beginning and end of each intervention period.

Results

A total of 20 participants completed the intervention and were analyzed, with walnuts being well tolerated. A significant decrease in waist circumference (p = 0.049) and a slight change in fasting blood glucose (p = 0.089) were noted following walnut intake.

Conclusions

Short-term (4 weeks) dietary supplementation with walnuts resulted in a statistically significant reduction in waist circumference while not impacting the overall health status of participants. Longer-term studies are necessary to investigate the benefits of daily walnut consumption and its impact on the onset and development of MetS in this age group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

JuglansMetabolic SyndromeNutsDietHumansMiddle AgedMaleFemaleAdultCross-Over StudiesBlood GlucoseVascular Cell Adhesion Molecule-1Lipids

Stichwörter der Autor:innen

Juglans regiablood pressurecholesterolchronic inflammationdyslipidemiaendothelial functionfasting blood glucoseglycemiaglycemic profilehypertensionlipid profiletriglycerideswaist circumference

Substanzen

Blood GlucoseVascular Cell Adhesion Molecule-1Lipids

Autor:innen und Institutionen

  • Department of Toxicology, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes, 400012 Cluj-Napoca, Romania.
  • Clinic of Occupational Medicine, Cluj County Emergency Clinical Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania.
  • Department of Bromatology, Hygiene, Nutrition, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, 6 Pasteur Street, 400349 Cluj-Napoca, Romania.
  • Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, 8 Victor Babes, 400012 Cluj-Napoca, Romania.
  • Department of Microbiology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • County Emergency Hospital Cluj-Napoca, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania.

ORCID-Profile: Letiția Mateș, Andreea-Elena Petru, Roxana Banc, Marius Emil Rusu, Carmen Costache, Lorena Filip, Daniela-Saveta Popa, Daniel-Corneliu Leucuța

Förderung

  • Iuliu Hațieganu University of Medicine and Pharmacy

Zitieren

APA

Mateș, L., Albert-Ani, D., Fizeșan, I., Petru, A. E., Banc, R., Rusu, M. E., Costache, C., Filip, L., Popa, D. S., & Leucuța, D. C. (2025). Benefits of Short-Term (4-Week) Daily Walnut Consumption in Middle-Aged Adults at Risk for Metabolic Syndrome: Outcomes of a Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu17132072

Vancouver

Mateș L, Albert-Ani D, Fizeșan I, Petru AE, Banc R, Rusu ME, et al. Benefits of Short-Term (4-Week) Daily Walnut Consumption in Middle-Aged Adults at Risk for Metabolic Syndrome: Outcomes of a Randomized Controlled Trial. Nutrients. 2025. doi:10.3390/nu17132072

BibTeX
@article{Mate2025,
  author = {Mateș, Letiția and Albert-Ani, Doina and Fizeșan, Ionel and Petru, Andreea-Elena and Banc, Roxana and Rusu, Marius Emil and Costache, Carmen and Filip, Lorena and Popa, Daniela-Saveta and Leucuța, Daniel-Corneliu},
  title = {Benefits of Short-Term (4-Week) Daily Walnut Consumption in Middle-Aged Adults at Risk for Metabolic Syndrome: Outcomes of a Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17132072}
}
Kostenlos starten →